DE69230890D1 - Bestimmung von nukleären matrixproteinen in flüssigkeiten - Google Patents
Bestimmung von nukleären matrixproteinen in flüssigkeitenInfo
- Publication number
- DE69230890D1 DE69230890D1 DE69230890T DE69230890T DE69230890D1 DE 69230890 D1 DE69230890 D1 DE 69230890D1 DE 69230890 T DE69230890 T DE 69230890T DE 69230890 T DE69230890 T DE 69230890T DE 69230890 D1 DE69230890 D1 DE 69230890D1
- Authority
- DE
- Germany
- Prior art keywords
- matrix proteins
- nuclear matrix
- liquids
- determination
- evaluating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US78580491A | 1991-10-31 | 1991-10-31 | |
PCT/US1992/009220 WO1993009437A2 (en) | 1991-10-31 | 1992-10-29 | Nuclear matrix protein fluid assay |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69230890D1 true DE69230890D1 (de) | 2000-05-11 |
DE69230890T2 DE69230890T2 (de) | 2000-12-07 |
Family
ID=25136671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69230890T Expired - Lifetime DE69230890T2 (de) | 1991-10-31 | 1992-10-29 | Bestimmung von nukleären matrixproteinen in flüssigkeiten |
Country Status (9)
Country | Link |
---|---|
US (8) | US5965376A (de) |
EP (1) | EP0642668B1 (de) |
JP (1) | JP3190042B2 (de) |
AT (1) | ATE191567T1 (de) |
AU (1) | AU658257B2 (de) |
CA (1) | CA2122473C (de) |
DE (1) | DE69230890T2 (de) |
ES (1) | ES2147555T3 (de) |
WO (1) | WO1993009437A2 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE191567T1 (de) | 1991-10-31 | 2000-04-15 | Matritech Inc | Bestimmung von nukleären matrixproteinen in flüssigkeiten |
JPH07509602A (ja) * | 1992-06-22 | 1995-10-26 | マトリテク インコーポレイテッド | 新規な悪性細胞型内部核マトリックスマーカー |
US5547928A (en) * | 1993-12-17 | 1996-08-20 | Matritech, Inc. | Methods and compositions for the detection of colon cancers |
US6280956B1 (en) | 1995-11-03 | 2001-08-28 | University Of Pittsburgh | Antibodies to bladder cancer nuclear matrix proteins and their use |
WO1997016206A1 (en) * | 1995-11-03 | 1997-05-09 | Getzenberg Robert H | Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders |
US5914238A (en) | 1996-06-05 | 1999-06-22 | Matritech, Inc. | Materials and methods for detection of breast cancer |
US5858683A (en) | 1996-08-30 | 1999-01-12 | Matritech, Inc. | Methods and compositions for the detection of cervical cancer |
US6232443B1 (en) * | 1997-04-08 | 2001-05-15 | University Of Pittsburgh | Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
ES2265682T3 (es) | 1998-03-18 | 2007-02-16 | Roche Diagnostics Gmbh | Deteccion de productos apoptoticos. |
US7229772B1 (en) | 1998-03-18 | 2007-06-12 | Roche Diagnostics Gmbh | Detection of apoptotic products |
CA2372783A1 (en) | 1999-05-17 | 2000-11-23 | Pro Duct Health, Inc. | Identifying material from a breast duct |
US20030228640A1 (en) | 1999-10-15 | 2003-12-11 | University Of Pittsburgh | Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
US6617432B1 (en) | 1999-10-15 | 2003-09-09 | University Of Pittsburgh | Nuclear matrix proteins polynucleotide sequences encoding them and their use |
KR100350111B1 (ko) | 2000-02-22 | 2002-08-23 | 삼성전자 주식회사 | 반도체 장치의 배선 및 이의 제조 방법 |
US7654227B1 (en) * | 2001-12-20 | 2010-02-02 | Pat Yananton | Absorbent pad for entrapping small and large particles, retaining liquids and eliminating odors |
US7080373B2 (en) * | 2001-03-07 | 2006-07-18 | Freescale Semiconductor, Inc. | Method and device for creating and using pre-internalized program files |
US20030044352A1 (en) * | 2001-04-24 | 2003-03-06 | Phillips Nigel C. | Method for evaluating the efficacy of treatment with bacterial DNA and bacterial cell walls |
US7193065B2 (en) * | 2001-07-13 | 2007-03-20 | Roche Diagnostics Operations, Inc. | Protease inhibitor conjugates and antibodies useful in immunoassay |
US20040018973A1 (en) * | 2002-01-25 | 2004-01-29 | University Of Pittsburgh | Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
JP4274856B2 (ja) * | 2003-06-19 | 2009-06-10 | オリンパス株式会社 | Dnaとdna結合タンパク質との反応を検出する方法 |
JP4425919B2 (ja) * | 2003-09-23 | 2010-03-03 | エヌエックスピー ビー ヴィ | 適応フィルタ |
US7649988B2 (en) | 2004-06-15 | 2010-01-19 | Acoustic Technologies, Inc. | Comfort noise generator using modified Doblinger noise estimate |
US7935479B2 (en) * | 2004-07-19 | 2011-05-03 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
JP5073491B2 (ja) * | 2004-07-19 | 2012-11-14 | プロテインシンプル | 分析対象物の検出のための方法 |
US7846676B2 (en) * | 2004-07-19 | 2010-12-07 | Cell Biosciences, Inc. | Methods and devices for analyte detection |
WO2006110725A2 (en) * | 2005-04-09 | 2006-10-19 | Cell Biosciences, Inc. | Automated micro-volume assay system |
ES2429564T3 (es) | 2005-05-18 | 2013-11-15 | Novartis Ag | Procedimientos para el diagnóstico y tratamiento de enfermedades que tienen un componente autoinmune y/o inflamatorio |
US20070015166A1 (en) * | 2005-07-14 | 2007-01-18 | Nilsen Thor W | Lateral flow methods and devices for detection of nucleic acid binding proteins |
US8945361B2 (en) | 2005-09-20 | 2015-02-03 | ProteinSimple | Electrophoresis standards, methods and kits |
US20080017512A1 (en) * | 2006-07-24 | 2008-01-24 | Bordunov Andrei V | Coatings for capillaries capable of capturing analytes |
WO2008057605A2 (en) * | 2006-11-10 | 2008-05-15 | Quidel Corporation | Nuclear protein extraction medium and method of use |
US20090023156A1 (en) * | 2007-07-20 | 2009-01-22 | Voss Karl O | Methods and reagents for quantifying analytes |
US10107782B2 (en) | 2008-01-25 | 2018-10-23 | ProteinSimple | Method to perform limited two dimensional separation of proteins and other biologicals |
JP2011206049A (ja) | 2010-03-08 | 2011-10-20 | Sumio Sugano | 壊死マーカー及びその用途 |
US9804079B2 (en) | 2012-04-19 | 2017-10-31 | ProteinSimple | Dual wavelength isoelectric focusing for determining drug load in antibody drug conjugates |
US9766206B2 (en) | 2013-09-27 | 2017-09-19 | ProteinSimple | Apparatus, systems, and methods for capillary electrophoresis |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4628027A (en) * | 1982-05-19 | 1986-12-09 | Molecular Engineering Associates, Ltd. | Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins |
US4882268A (en) * | 1985-12-24 | 1989-11-21 | Massachusetts Institute Of Technology | Method for determining tissue of origin and degree of malignancy of tumor cells |
US5273877A (en) * | 1985-12-24 | 1993-12-28 | Massachusetts Institute Of Technology | Non-histological cell type determination |
US5032508A (en) * | 1988-09-08 | 1991-07-16 | Marrow-Tech, Inc. | Three-dimensional cell and tissue culture system |
US4806463A (en) * | 1986-05-23 | 1989-02-21 | Worcester Foundation For Experimental Biology | Inhibition of HTLV-III by exogenous oligonucleotides |
US4861581A (en) * | 1986-12-05 | 1989-08-29 | Cancer Biologics, Inc. | Detection of necrotic malignant tissue and associated therapy |
US4937185A (en) * | 1987-07-31 | 1990-06-26 | The Ohio State University Research Foundation | Detection of circulating antibodies to a cancer marker protein |
WO1989006697A1 (en) * | 1988-01-19 | 1989-07-27 | The University Of Sydney | Detection of cell death |
US5017474A (en) * | 1988-02-12 | 1991-05-21 | Eastman Kodak Company | Wash solution, test kit and method for the determination of an immunological ligand |
US5098890A (en) * | 1988-11-07 | 1992-03-24 | Temple University-Of The Commonwealth System Of Higher Education | Antisence oligonucleotides to c-myb proto-oncogene and uses thereof |
JP2706568B2 (ja) * | 1990-05-01 | 1998-01-28 | アイシス・ファーマシューティカルス・インコーポレーテッド | 新規な薬物および試薬の同定 |
ATE191567T1 (de) * | 1991-10-31 | 2000-04-15 | Matritech Inc | Bestimmung von nukleären matrixproteinen in flüssigkeiten |
WO1993009142A1 (en) * | 1991-11-08 | 1993-05-13 | University Of Saskatchewan | Acute phase proteins for detection and prognosis of infection and tissue damage |
WO1993021531A1 (en) * | 1992-04-15 | 1993-10-28 | Brigham And Women's Hospital, Inc. | Method and composition for the detection of lesions |
JPH07509602A (ja) * | 1992-06-22 | 1995-10-26 | マトリテク インコーポレイテッド | 新規な悪性細胞型内部核マトリックスマーカー |
-
1992
- 1992-10-29 AT AT92925031T patent/ATE191567T1/de active
- 1992-10-29 JP JP50855693A patent/JP3190042B2/ja not_active Expired - Lifetime
- 1992-10-29 CA CA002122473A patent/CA2122473C/en not_active Expired - Lifetime
- 1992-10-29 EP EP92925031A patent/EP0642668B1/de not_active Expired - Lifetime
- 1992-10-29 DE DE69230890T patent/DE69230890T2/de not_active Expired - Lifetime
- 1992-10-29 AU AU31235/93A patent/AU658257B2/en not_active Expired
- 1992-10-29 ES ES92925031T patent/ES2147555T3/es not_active Expired - Lifetime
- 1992-10-29 WO PCT/US1992/009220 patent/WO1993009437A2/en active IP Right Grant
-
1995
- 1995-05-18 US US08/443,630 patent/US5965376A/en not_active Expired - Lifetime
- 1995-05-18 US US08/444,821 patent/US5840503A/en not_active Expired - Fee Related
- 1995-06-01 US US08/456,620 patent/US5989826A/en not_active Expired - Lifetime
-
1999
- 1999-07-21 US US09/357,898 patent/US6162608A/en not_active Expired - Fee Related
-
2000
- 2000-10-12 US US09/687,188 patent/US6410247B1/en not_active Expired - Fee Related
-
2002
- 2002-05-20 US US10/151,717 patent/US6740494B2/en not_active Expired - Fee Related
-
2003
- 2003-10-27 US US10/694,629 patent/US20050059026A1/en not_active Abandoned
-
2006
- 2006-02-02 US US11/346,457 patent/US20060127941A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE69230890T2 (de) | 2000-12-07 |
US20030096304A1 (en) | 2003-05-22 |
US20050059026A1 (en) | 2005-03-17 |
AU658257B2 (en) | 1995-04-06 |
US6162608A (en) | 2000-12-19 |
CA2122473C (en) | 2001-01-23 |
JPH07500671A (ja) | 1995-01-19 |
JP3190042B2 (ja) | 2001-07-16 |
US5989826A (en) | 1999-11-23 |
US6740494B2 (en) | 2004-05-25 |
EP0642668B1 (de) | 2000-04-05 |
EP0642668A1 (de) | 1995-03-15 |
WO1993009437A2 (en) | 1993-05-13 |
WO1993009437A3 (en) | 1993-06-10 |
US5965376A (en) | 1999-10-12 |
CA2122473A1 (en) | 1993-05-13 |
US5840503A (en) | 1998-11-24 |
US6410247B1 (en) | 2002-06-25 |
US20060127941A1 (en) | 2006-06-15 |
AU3123593A (en) | 1993-06-07 |
ES2147555T3 (es) | 2000-09-16 |
ATE191567T1 (de) | 2000-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69230890D1 (de) | Bestimmung von nukleären matrixproteinen in flüssigkeiten | |
ATE205602T1 (de) | Verfahren und gerät zum nachweis und zur quantifizierung von glukose in körperflüssigkeiten | |
ATE543T1 (de) | Diagnostisches mittel, verfahren zu dessen herstellung sowie dessen verwendung zum nachweis von leukozyten in koerperfluessigkeiten. | |
DE69110098D1 (de) | Teststreifen zur visuellen Bestimmung der Blutglucosekonzentration. | |
IT1230178B (it) | Procedimento e dispositivo per l'analisi quantitativa e differenziale in profondita' di provini solidi con l'impiego di due raggi ionici | |
ATE263505T1 (de) | Mittels vakuum verbesserter transdermaler flüssigkeitstransport | |
DE59007613D1 (de) | Verfahren zum Nachweis und zur Bestimmung von Humanserumalbumin in biologischen Flüssigkeiten mit Hilfe fluorogener Cyanin-Farbstoffe. | |
DE3882804T2 (de) | Apparat zum Nachweis von bestimmten Stoffen in Urin, ein Klosett und ein System zur Sammlung von Gesundheitsinformation. | |
DE3880118D1 (de) | Verwendung eines mittels in form von mikrokapseln zur schabenbekaempfung. | |
DE68925481T2 (de) | Verfahren zum nachweis von bakterien im harn | |
FI912050A0 (fi) | Menetelmä ihmisen papilloomaviruksen (HPV) toteamiseksi diagnostista käyttöä varten | |
DE3888998D1 (de) | Verfahren zur Bestimmung eines Antikörpers in menschlichen Körperflüssigkeiten. | |
SE8701905L (sv) | Foerfarande och kit foer diagnos av iga-nefropati | |
IT8921788A0 (it) | Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici. | |
ES2078733T3 (es) | Metodo para la deteccion de anticuerpos anti-arn. | |
DE69428278D1 (de) | Leukozytadhaesiontest | |
IT8423926A0 (it) | Metodo diagnostico per la valutazione di parametri clinici mediante prelievo diretto dimateriali biologici e dispositivoper la sua attuazione. | |
ES8700440A1 (es) | Metodo y equipo para detectar la presencia de aminas | |
DK70488D0 (da) | Fremgangsmaade til paavisning af antistoffer i blod, samt membran og test-saet til anvendelse ved udoevelse af fremgangsmaaden | |
NO893904D0 (no) | Fremgangsmaate for aa bestemme oksyderbare organiske forbindelser i et vaeske- og/eller gassmedium. | |
DE69023500D1 (de) | Verfahren zum nachweis von antikörpern gegen streptokinase. | |
NO904548L (no) | Paavisning, kvantifisering og klassifikasjon av ras-proteiner i kroppsfluider og -vev. | |
IT8867856A0 (it) | Procedimento per la rivelazione di sangue occulto nelle feci | |
DE29819276U1 (de) | Testsystem zum nicht-invasiven Nachweis von in Körperflüssigkeiten vorhandenen Antigenen oder Antikörpern | |
DE3890854T1 (de) | Ultraschallverfahren und -vorrichtung, insbesondere zur pruefung von dichtem gewebe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: MATRITECH, INC. (N.D.GES.D. STAATES DELAWARE),, US |
|
R071 | Expiry of right |
Ref document number: 642668 Country of ref document: EP |